- Report
- March 2024
- 187 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- March 2024
- 147 Pages
Global
From €3745EUR$3,899USD£3,224GBP
- Report
- November 2023
- 180 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- February 2024
- 125 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Report
- May 2023
- 799 Pages
Global
From €2401EUR$2,500USD£2,067GBP
- Report
- May 2023
- 67 Pages
Global
From €3357EUR$3,495USD£2,890GBP
- Report
- October 2023
- 170 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4754EUR$4,950USD£4,093GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4754EUR$4,950USD£4,093GBP
- Report
- October 2023
- 82 Pages
United States
From €3362EUR$3,500USD£2,894GBP
- Drug Pipelines
- July 2022
- 100 Pages
Global
From €2641EUR$2,750USD£2,274GBP
- Report
- April 2023
- 84 Pages
Europe
From €4226EUR$4,400USD£3,638GBP
- Report
- September 2022
- 159 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- February 2022
- 113 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2022
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2022
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2022
- 60 Pages
Global
From €3794EUR$3,950USD£3,266GBP
The Dementia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Dementia drugs are used to treat the cognitive decline associated with Alzheimer's disease, vascular dementia, and other forms of dementia. These drugs are typically prescribed to improve memory, thinking, and behavior, as well as to slow the progression of the disease. Common dementia drugs include cholinesterase inhibitors, memantine, and glutamate modulators.
Some companies in the Dementia Drug market include Pfizer, Novartis, Merck, and Eli Lilly. Other companies include Biogen, AstraZeneca, and Johnson & Johnson. Show Less Read more